Anita C. Cortez

Agulha, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Dengue Fever in Patients with Hematological Malignancies and Hematopoietic Stem Cell Transplantation Recipients: Clinical Characteristics and Outcomes.

Dengue Fever in Patients with Hematological Malignancies and Hematopoietic Stem Cell Transplantation Recipients: Clinical Characteristics and Outcomes.

Journal: Transplantation and cellular therapy

Published: April 18, 2026

Outcomes of loncastuximab tesirine in heavily pretreated patients with diffuse large B-cell lymphoma, including the post-CAR T-cell therapy setting: A meta-analysis.

Outcomes of loncastuximab tesirine in heavily pretreated patients with diffuse large B-cell lymphoma, including the post-CAR T-cell therapy setting: A meta-analysis.

Journal: Cancer

Published: March 01, 2026

FLUOROQUINOLONE PROPHYLAXIS FOR FEBRILE NEUTROPENIA IN AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION: OUTCOMES AND RISK FACTORS.

FLUOROQUINOLONE PROPHYLAXIS FOR FEBRILE NEUTROPENIA IN AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION: OUTCOMES AND RISK FACTORS.

Journal: Acta haematologica

Published: August 08, 2025

Fluoroquinolone Prophylaxis for Febrile Neutropenia in Autologous Hematopoietic Cell Transplantation: Outcomes and Risk Factors.

Fluoroquinolone Prophylaxis for Febrile Neutropenia in Autologous Hematopoietic Cell Transplantation: Outcomes and Risk Factors.

Journal: Acta haematologica

Published: August 08, 2025

Adherence to the febrile neutropenia protocol in pediatric leukemia patients at a Brazilian Cancer Center-A retrospective audit.

Adherence to the febrile neutropenia protocol in pediatric leukemia patients at a Brazilian Cancer Center-A retrospective audit.

Journal: Pediatric hematology and oncology

Published: July 01, 2025

Acute fibrinous and organizing pneumonia after bone marrow transplantation, an underrecognized, severe condition.

Acute fibrinous and organizing pneumonia after bone marrow transplantation, an underrecognized, severe condition.

Journal: Hematology, transfusion and cell therapy

Published: November 17, 2024

Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study.

Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study.

Journal: Infectious diseases and therapy

Published: September 27, 2024

An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab.

An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab.

Journal: Cancer medicine

Published: October 18, 2023

Comparing the Real-World Use of Isavuconazole to Other Anti-Fungal Therapy for Invasive Fungal Infections in Patients with and without Underlying Disparities: A Multi-Center Retrospective Study.

Comparing the Real-World Use of Isavuconazole to Other Anti-Fungal Therapy for Invasive Fungal Infections in Patients with and without Underlying Disparities: A Multi-Center Retrospective Study.

Journal: Journal of fungi (Basel, Switzerland)

Published: December 30, 2022

The role of autologous bone marrow transplantation in primary effusion lymphoma: a case report and literature review.

The role of autologous bone marrow transplantation in primary effusion lymphoma: a case report and literature review.

Journal: Hematology, transfusion and cell therapy

Published: June 19, 2022

Vaginal ALK-positive anaplastic large cell lymphoma treated with brentuximab vedotin: a case report and literature review.

Vaginal ALK-positive anaplastic large cell lymphoma treated with brentuximab vedotin: a case report and literature review.

Journal: Hematology, transfusion and cell therapy

Published: August 24, 2021

Unusual presentation of a primary low-grade central nervous system lymphoma.

Unusual presentation of a primary low-grade central nervous system lymphoma.

Journal: Hematology, transfusion and cell therapy

Published: November 27, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026